Gangliosides are known as modulators of transmembrane signaling by regulating various receptor functions. We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-α) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression due to elevating GM3 synthase activity and its mRNA. We also demonstrated that TNF-α simultaneously produced insulin resistance by uncoupling insulin receptor activity toward insulin receptor substrate-1 (IRS-1) and suppressing insulin-sensitive glucose transport. Pharmacological depletion of GM3 in adipocytes by an inhibitor of glucosylceramide synthase prevented the TNF-α-induced defect in insulindependent tyrosine phosphorylation of IRS-1 and also counteracted with the TNF-α-induced serine phosphorylation of IRS-1. Moreover, when the adipocytes were incubated with exogenous GM3, suppression of tyrosine phosphorylation of insulin receptor and IRS-1, and glucose uptake in response to insulin stimulation was observed, demonstrating that GM3 itself is able to mimic the effects of TNF on insulin signaling. We used the obese Zucker fa/fa rat and ob/ob mouse, which are known to overproduce TNF-α mRNA in adipose tissues, as typical models of insulin resistance. We found that the levels of GM3 synthase mRNA in adipose tissues of these animals were significantly higher than in their lean counterparts. Taken together, the increased synthesis of cellular GM3 by TNF may participate in the pathological conditions of insulin resistance in type 2 diabetes.
INTRODUCTION
Insulin resistance is defined as decreased ability of cells or tissues to respond to physiological levels of insulin and is a characteristic condition of type 2 diabetes (1).
Several lines of evidence suggest that tumor necrosis factor TNF-α represents a key mediator of obesity-linked insulin resistance. First, overexpression of TNF-α in adipose tissue and insulin resistance were commonly observed in different rodent models of obesity (2, 3) as well as in obese humans (4) . Second, neutralization of TNF with a soluble TNF receptor-immunoglobulin G chimeric protein was found to improve insulin receptor signaling and insulin sensitivity in obese and insulin resistant rats (2) .
Moreover, obese mice with targeted disruption of the genes encoding either TNF or its two receptors lacked insulin resistance (5) . Third, on a cellular level, TNF is a potent inhibitor of insulin signaling. Chronic treatment of 3T3-L1 adipocytes with TNF inhibits glucose uptake and interferes with signaling through the insulin receptor to downstream of substrates, such as insulin receptor substrate-1 (IRS-1), suggesting a defect at or near the tyrosine kinase activity (6) . Although there is now substantial evidence linking TNF to the presentation of insulin resistance in humans, animals, and in vitro systems as described above, the molecular mechanisms mediating the cross talk between TNF-α and the insulin signaling cascade remain incompletely understood.
A key question is whether TNF acts directly or indirectly to suppress insulin function.
It has been shown that TNF causes downregulation of the insulin-regulatable glucose transporter, GLUT4, expressed in cultured adipocytes (2, 7) . Since GLUT4 is also known to be deficient in adipose tissues of several obese animal models as well as humans with by guest on http://www.jbc.org/ Downloaded from 4 type 2 diabetes (8, 9) , TNF-mediated insulin resistance in these disorders may involve the regulation of GLUT4 expression. However, an additional step in insulin action targeted by TNF has been suggested, since TNF at relatively low concentrations can strongly inhibit insulin-stimulated glucose uptake in cultured adipocytes without affecting cell content of insulin receptor, IRS-1, or GLUT4 proteins (6) . Moreover, partially purified insulin receptors isolated from TNF-α-treated adipocytes showed reduced autophosphorylation of insulin receptor and reduced tyrosine phosphorylation of exogenously added IRS-1, suggesting the presence of co-purifying inhibitory molecule(s) (6) . It would be important to purify and characterize these molecules. It has been reported recently that mice disrupted with p55 TNF receptor 1 (TNFR1) exhibited altered ganglioside expressionincluding a decrease in ganglioside GM3 (10) -suggesting that ganglioside metabolism is regulated at least in part by TNF signaling. Gangliosides have been suggested to be involved in signal transduction through their interaction with receptors such as epidermal growth factor receptor (11), platelet derived growth factor receptor (12) and insulin receptor (13) . This paper examines the effects of TNF enhancement and depletion of ganglioside GM3 on the control of insulin signaling. 
Cell line and culture conditions
Murine 3T3-L1 preadipocytes were cultured, maintained, and differentiated as described previously (15) . Briefly, cells were seeded and grown for 2 days postconfluence in DMEM supplemented with 10% calf serum. Differentiation was then induced by changing the medium to DMEM supplemented with 10% fetal bovine serum, 0.5 mM 3-isobutyl-1-methylxanthine, 1 µM dexamethasone, and 1.7 µM insulin. After 72 h, the differentiation medium was replaced with maintenance medium containing DMEM supplemented with 10% fetal bovine serum and 100 ng/ml insulin. 9 12 days after the induction of differentiation, >95% of the cells had the morphological and biochemical properties of adipocytes. The maintenance medium was changed every 48 h until the cells were utilized for experimentation. Human TNF-α was dissolved in phosphate-buffered saline containing 0.1% fatty acid-free and growth factor-depleted bovine serum albumin (Sigma) and was added to the cell culture media. For chronic cytokine treatments, fully differentiated adipocytes maintained in DMEM containing 10% fetal bovine serum and 100 ng/ml insulin were incubated in the absence or presence of 0.1 nM TNF-α for 96 h, as described previously (16) . The cells were then incubated in serum-free DMEM containing 0.5% bovine serum albumin, with or without 0.1 nM TNF and stimulated with 100 nM insulin for 3 min for the study of insulin-induced tyrosine phosphorylation. Alternatively, cells were cultured in phosphate-free medium for metabolic radiolabeling of phosphorylated proteins. Adipocytes were also treated with 20 µM D-PDMP or gangliosides as indicated in each figure.
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Immunoprecipitation and Immunoblotting
After treatments, 3T3-L1 adipocytes were washed twice with ice-cold phosphatebuffered saline and lysed by incubation in immunoprecipitation (IP) buffer (50 mM Hepes, pH 7.0, 150 mM NaCl, 10% glycerol, 1.2% Triton X-100, 1.5 mM MgCl 2 , 1 mM EGTA, 10 mM sodium pyrophosphate, 100 mM NaF, 1 mM phenylmethylsulfonyl fluoride, 0.15 unit/ml aprotinin, 10 µg/ml leupeptin, 10 µg/ml pepstatin A, and 1 mM sodium orthovanadate) for 30 min at 4 . The lysate was centrifuged (150,000 x g, 1 h), and the infranatant was removed from the fat and the extracts (1-1.5 mg of protein) were subjected to immunoprecipitation and followed by Western blotting using appropriate antibodies (16) .
Ganglioside analysis
The total lipids were extracted from the cells with chloroform/methanol/water (4:4:0.3, 2:4:0.3, v/v/v), successively, and purified to obtain acidic glycolipid fraction as described (17) .
Ganglioside composition was determined by TLC plate with chloroform/methanol/water (65:25:4). Gangliosides were visualized by spraying resorcinol reagent followed by heating at 105˚C for 10 min. Since 3T3-L1 adipocytes express GM3
as the primary ganglioside (18) , the quantity of GM3 in the cells was measured with a dual-wavelength flying spot scanner (CS9000, Shimadzu, Kyoto, Japan) in the reflectance mode at 500 nm with area integration.
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GM3 synthase assay
Cells cultured in a 100 mm dish were harvested using a scraper and washed three times with PBS. The cells were resuspended in 300 µl of Tris buffered saline (pH 7.4) containing 0.1% Triton X-100 and homogenized by sonication on ice. GM3 synthase activity was measured as described (19) Receptor Binding Assay
Insulin binding to adipocytes was measured by a previously described technique (20) with slight modification. In brief, 3T3-L1 adipocytes were treated with or without 20 µM 
Northern blot analysis of GM3 synthase mRNA
Total RNA (5 µg) from adipose tissues was denatured in 50% (v/v) formamide, 6%
(v/v) formaldehyde, 20 mM 3-morpholinopropanesulfonic acid (pH 7.0) at 65˚C, electrophoresed on 1% agarose gel containing 6% formaldehyde, blotted onto a Nylon membrane (Boehringer Mannheim, Mannheim, Germany), and cross-linked by UV irradiation. A digoxigenin-labeled RNA probe for mouse GM3 synthase, mSAT-1, (22) was synthesized from the XhoI-fragment of pBS-SAT-1 using a DIG RNA Labeling kit with T7 RNA polymerase (Boehringer Mannheim) according to the manufacturer's instruction. The membrane was hybridized with the RNA probe at 68˚C, and detection was carried out with a DIG-Luminescent Detection kit (Boehringer Mannheim).
Determination of glucose uptake
The assay of [ 3 H]2-deoxyglucose uptake was performed as described previously (20) .
Prior to the assay, the cells were deprived of serum for 8 h. Uptake measurement were made in triplicate under conditions when hexose uptake was linear, and the results were corrected for nonspecific uptake and absorption was determined by [ 3 H]2-deoxyglucose uptake in the presence of 5 µM cytochalasin B. Nonspecific uptake and absorption was always less than 10% of the total uptake.
Phosphoamino Acid Analysis of IRS-1
Cells were washed twice in DMEM lacking phosphate and incubated for 6 h in DMEM lacking phosphate supplemented with 10% fetal bovine serum dialyzed against saline in the presence or absence of TNF, D-PDMP and GM3 as specified in each figure. During the last 5 h, metabolic labeling of phosphoproteins was carried out in the presence of 2 mCi containing 0.1% SDS and 5% mercaptoethanol for overnight. After centrifugation, 10 µl of BSA (10 mg/ml) was added to the supernatants, and the proteins were precipitated by 10% trichloroacetic acid at 4˚C for 1 h, washed with 0.5 ml ice-cold acetone twice and air dried.
11
The trichloroacetic acid precipitates were dissolved in 50 µl of 6N HCl, hydrolyzed at 110˚C for 90 min, and dried in a speedVac centrifuge. Residues were dissolved in 5 µl of 2 mg/ml standards (phosphotyrosine, phosphoserine, and phosphothreonine mixture). 3 µl of each sample were spotted on a TLC cellulose plate (Merck) and separated in running buffer (acetic acid: pyridine: water, 10:1:189) by electrophoresis at 500 V for 120 min on a
Hunter thin layer peptide mapping system NB-4000B (Nihon Eido, Tokyo, Japan).
Standards of phosphoamino acids were visualized ninhydrin staining (0.25% in acetone), and radioactive amino acid was visualized by autoradiography (23) .
RESULTS
Effect of TNF-on Components of the Insulin Receptor Signaling and Ganglioside
Expression TNF-α binds to two receptors, the 55-kDa type 1 receptor and 75-kDa type 2 receptor (24) . Murine TNF receptors display species specificity toward TNFs; whereas murine TNF-α binds to both receptors, human TNF-α is selectively recognized by the 55-kDa type 1 receptor (25) . In studies using genetically obese ob/ob mice, TNF receptor wild type and p75 receptor knockout animals developed insulin resistance, but p55 receptor knockout animals did not, demonstrating that TNF signaling through the p55 receptor is more important in development of insulin resistance than that through the p75 receptor (5).
Therefore, we employed human TNF throughout this study to investigate the signaling events elicited from the p55 receptor in murine 3T3 L-1 adipocytes.
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Since it has been demonstrated that ganglioside metabolism is regulated at least in part by TNF signaling (10), we examined the cell surface expression of GM3, which is the major ganglioside of 3T3-L1 cells (18) , by flowcytometry using anti-GM3 antibody (M2590). The expression was progressively increased after TNF treatment at a concentration of 0.1 nM (Fig. 1A) . The increase was seen as early as 3 h, reached a plateau at 48 h, and maintained the high level during the long-term treatment with TNF (96 h).
Corresponding to the result of Fig. 1A , both TLC analysis of cellular GM3 content ( Fig.   1B ) and GM3 synthase activity (Fig. 1C) were increased in parallel. The major ganglioside of adipocytes was GM3 and a small amount of GD1a was present; the latter did not change with TNF treatment. The increased GM3 expression by TNF could be attributed to the increased GM3 synthase mRNA level demonstrated by RT-PCR (Fig. 1D ).
Effects of TNF-and D-PDMP on Insulin Signaling through Insulin Receptor to
IRS-1
We first examined the effects of low TNF concentrations on the levels of the insulin receptor and IRS-1 proteins, since high concentrations of TNF induce dedifferentiation of adipocytes (2, 26) and reduces gene expression on components of the insulin receptor signal transduction pathway, such as IRS-1 and GLUT4 genes (2, (6) (7) (8) (9) 27 ). Fully differentiated 3T3-L1 adipocytes were treated with 0.1 nM TNF for 96 h as described previously (16) , and whole cell lyzates were immunoprecipitated with anti-IRS-1 antibody and probed by Western blotting. We have confirmed that there was no obvious decrease in IRS-1 ( Fig. 2A) . Under the same treatment conditions with TNF present, significant by guest on September 1, 2017
http://www.jbc.org/ Downloaded from 13 inhibition of the glucose uptake was observed (Fig. 6 ). Therefore, we employed these treatment conditions in the following experiments to produce a state of insulin resistance without affecting the expression of IRS-1.
We have confirmed that chronic treatment (96 h) of 0.1 nM TNF-α was capable of inducing the state of insulin resistance of adipocytes, based on the abilities of insulin to induce tyrosine phosphorylation of β subunit of its own receptor and IRS-1 (Fig. 2) as well as the glucose uptake (Fig. 6 ). TNF induced a moderate decrease of insulin stimulated phosphorylation of the insulin receptor and a more pronounced inhibition of insulinpromoted phosphorylation of IRS-1 without affecting expression of either the insulin receptor or IRS-1 ( Fig. 2A ).
Marked accumulation of GM3 was occurred with TNF treatment (Fig. 1B and 2B ).
One approach to depleting cellular gangliosides is the use of inhibitor of glucosylceramide synthase, D-PDMP, a well-known tool for studying various functional roles of endogenous glycosphingolipids including gangliosides (14, 28) . D-PDMP lowered GM3 content in 3T3-L1 adipocytes treated without or with TNF (Fig. 2B) , with a concomitant increase of tyrosine phosphorylation of IRS-1 in response to insulin stimulation ( Fig. 2A) . To determine if the changes in tyrosine phosphorylation of insulin receptor and IRS-1 observed in Fig. 2A were due to an alteration of insulin receptor binding characteristics, competition binding curves were performed on D-PDMP-treated and control cells (Fig. 3) . 
Effects of Exogenous Gangliosides on Insulin Signaling
The effect of exogenously added gangliosides on tyrosine phosphorylation of IRS-1 in response to insulin stimulation was examined (Fig. 4) . Tyrosine phosphorylation of IRS-1 was greatly decreased only when 3T3-L1 adipocytes were incubated for 12 h with 100 µM GM3 but not with GD1a (a minor ganglioside of 3T3 L-1 cells) (Fig. 4A) . In order to see the effect of GM3 on both insulin receptor and IRS-1, we performed larger scale experiments. These demonstrated marked decrease of autophosphorylation of the insulin receptor and the subsequent suppression of tyrosine phosphorylation of IRS-1 (Fig. 4B) .
Effect of GM3 depletion on TNF--induced Serine Phosphorylation of IRS-1
It has been reported that exposure of adipocytes to TNF results in the increased serine phosphorylation of IRS-1 and this modified form of IRS-1 acts as an inhibitor in vitro (29, 30) . Therefore, we examined whether the increased GM3 in adipocytes affected the level of serine phosphorylation of IRS-1 by phosphoamino acid analysis of as done in Fig. 2B , there was no increase on the level of serine phosphorylation of IRS-
Effect of GM3 on Glucose Transport
Since exogenous GM3 selectively inhibited insulin-dependent tyrosine phosphorylation of IRS-1 (Fig. 4) , a question arises whether GM3 can affect the glucose transport of 3T3-L1 adipocytes. It is known that prolonged treatment of adipocytes with TNF is needed to induce suppression of glucose uptake (6) . Therefore, we first compared the glucose uptake when the cells were cultured for 6 or 96 h in the presence of 100 µM GM3. The inhibitory effect of GM3 on glucose uptake could be seen only after the 96 h of treatment. As shown in Fig. 6 , exogenous GM3 significantly suppressed glucose uptake to a similar degree when the cells were incubated with 0.1 nM TNF for 96 h. Thus, GM3
itself was able to reproduce a state of insulin resistance.
Enhanced Expression of GM3 Synthase mRNA in Adipose Tissues from Typical Rodent Models of Insulin Resistance
It was shown that adipose tissues of the obese-diabetic db/db, ob/ob, KKYa mice, and the Zucker fa/fa rat produced significant levels of TNF-α (2). animals. (Fig. 7) .
DISCUSSION
Recent studies examining the link between insulin resistance and the development of obesity and type 2 diabetes are consistent with the involvement of TNF-α as a central mediator (31, 32) . With respect to adipocytes, TNF, when applied at fairly high doses, causes suppression of most lipogenic enzymes, including lipoprotein lipase, and induces de-differentiation (2, 26) , and reduces expression of components of the insulin receptor signal transduction pathway, such as IRS-1 and GLUT4 genes (2, 6-9, 27). However, the interference with insulin action by TNF also occurs at doses (<0.1 nM) that are insufficient to cause a generalized suppression of adipocyte gene expression (6, 9) . This requires the prolonged treatment (at least 72 h), unlike many acute effects of this cytokine. The slowness of the effect suggests that TNF induces the synthesis of an inhibitor that is the actual effector.
We confirmed these previous observations using 3T3-L1 adipocytes in In the present study, we demonstrated that a state of insulin resistance in adipocytes treated with 0.1 nM TNF was accompanied with the progressive increase of cell surface GM3. This was mirrored with the increases of cellular GM3 content, GM3 synthase activity and GM3 synthase mRNA content, indicating that TNF upregulates GM3 synthesis at transcriptional level in cultured adipocytes. We could extend this in vitro observation to intact animals, since GM3 synthase mRNA contents in adipose tissues from the obese Zucker fa/fa rats and ob/ob mice were significantly high in comparison to their lean animal versions (Fig. 7) . Since it has been reported that adipose tissues from various species, including human, rabbit, rat, and mouse, contain GM3 as the most abundant type of ganglioside (33), we are currently analyzing the level of GM3 expression in adipose tissues from other rodent models as well as from humans with type2 diabetes. It is reasonable to speculate that the transcription of GM3 synthase gene is activated by TNF signaling through TNFR1. Since we now understand the involvement of nuclear factorkappa B, c-Jun, etc in TNF-stimulated gene transcription (34) , it is important to identify such TNF-stimulated response element(s) to induce transcription of GM3 synthase gene in adipocytes acquired insulin resistance.
To elucidate whether the increased GM3 in 3T3-L1 adipocytes treated with TNF is involved in insulin resistance, we employed two separate experimental approaches here (reduction or enrichment of cellular GM3). First, we used an inhibitor of glucosylceramide synthase, D-PDMP (14, 28) , to deplete cellular glycosphingolipids derived from glucosylceramide. This inhibitor is able to reduce ganglioside content with minimum effect on phospholipids, neutral lipids, and glycoprotein (35) . D-PDMP proved to be able to counteract TNF-induced increase of GM3 content in adipocytes and completely normalize the TNF-induced defect in tyrosine phosphorylation of IRS-1 in response to insulin stimulation (Fig. 2) . Thus, we were encouraged to measure the effect of PDMP on the TNF-induced defect of glucose uptake, but so far we could not see recovery of glucose uptake (data not shown). This may mean that D-PDMP effectively normalized the TNFinduced suppression at the initial step of insulin signaling by depleting GM3 but was not be able to counteract the TNF-induced suppression of GLUT4 expression or its translocation to plasma membrane. Nevertheless, the possible therapeutic implication for insulin resistance will be pursued more extensively because we have recently succeeded in developing a new potent inhibitor of glucosylceramide synthase (D-PBPP) which has no general cytotoxic effect (36) . Second, we examined the effect of exogenously added gangliosides on tyrosine phosphorylation of insulin receptor and IRS-1 (Fig. 4) , and glucose transport in response to insulin stimulation (Fig. 6) . Autophosphorylation of insulin receptor and subsequent tyrosine phosphorylation of IRS-1 were significantly reduced only when adipocytes were incubated with 100 µM GM3 but not with GD1a (a minor ganglioside of this cell line). If the inhibition of insulin receptor to IRS-1 signaling by exogenous GM3 directly results in producing a state of insulin resistance, the downstream of events such as the glucose uptake should also be interfered. Indeed, insulin-sensitive glucose uptake after prolonged treatment with GM3 was also suppressed, demonstrating that GM3 itself is able to reproduce a state of insulin resistance.
How can upregulation of GM3 synthesis in adipocytes exposed to TNF lead to the suppression of insulin signaling? A series of studies showed that gangliosides may inhibit or activate signal transduction through growth factor receptor or hormone receptor function, particularly associated with tyrosine kinase (for review see ref. 37, 38) . It has been reported that GM3 inhibits fibroblast growth factor (FGF) receptor function (39) and epidermal growth factor (EGF) receptor tyrosine kinase (11) will be important to identify the actual kinase(s) activated by endogenous GM3. We examined the effect of exogenous addition of GM3 on serine phosphorylation of IRS-1.
However, there was no obvious effect on serine phosphorylation of IRS-1 so far examined (data not shown), suggesting the differences of endogenous vs. artificial exogenous GM3
on the effects of serine phosphorylation of IRS-1. In order to solve this issue, we are trying to transfect GM3 synthase gene into adipocytes and other cell lines to identify the direct target(s) of endogenous GM3 responsible for insulin resistance.
In conclusion, we could present evidence for the first time that acquisition of a state of insulin resistance in adipocytes induced by TNF-α may depend upon increased GM3 biosynthesis through upregulation of GM3 synthase gene expression. Ganglioside GM3 may function as an inhibitor in insulin signaling during the chronic exposure of adipocytes to TNF. presence of TNF and PDMP as in (A) and ganglioside fraction was prepared as described in "Experimental Procedures". GM3 was visualized by resorcinol staining as in Fig. 1B and quantitated by densitometry. Northern blot analysis of GM3 synthase mRNA was performed using total mRNA form adipose tissues of Zucker fa/fa rats and ob/ob mice, and their lean counterparts. 
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